Fermenta Biotech Q1 FY27 results: Revenue Rs 121 Cr, PAT Rs 9 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Venkys India Q1 FY27 results: Revenue Rs 1,118 Cr, PAT Rs 49 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Vidya Wires Q1 FY27 results: Revenue Rs 549 Cr, PAT Rs 17 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Mobavenue AI Q1 FY27 results: Revenue Rs 72 Cr, PAT Rs 11 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Arfin India Q1 FY27 results: Revenue Rs 212 Cr, PAT Rs 4 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Five pros including global medical device exports and import substitution, and four cons including raw material cost risk and global market regulatory complexity, of Poly Medicure share.

Aeroflex Industries Q1 FY27 results: Revenue Rs 188 Cr, PAT Rs 103 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Walchandnagar Industries Q1 FY27 results: Revenue Rs 90 Cr, PAT Rs 1 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

JNK India Q1 FY27 results: Revenue Rs 179 Cr, PAT Rs 9 Cr. Key highlights, performance, FY27 outlook. Read full results analysis here.

Five pros including ORS leadership and strong cash generation, and four cons including limited growth diversification and branded generic competition, of FDC Limited share.